SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
$97.74 -1.01 (-1.0228%)
Analysed SPYRE THERAPEUTICS INC (SYRE:NASDAQ) News Sources
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares
17-05-2026
fool.com
Why Spyre Therapeutics (SYRE) Is Down 6.1% After Broadening Its SPY003 Paragon License Terms
02-06-2026
yahoo.com
Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
03-06-2026
yahoo.com
Spyre Therapeutics (SYRE): 12 Best High Short Interest Stocks With Highest Upside Potential
04-06-2026
yahoo.com
SYRE Completes Enrollment in SKYWAY Basket Study on SPY072, Stock Up
04-06-2026
yahoo.com
Spyre Announces Potential Best-in-Class SPY002 (anti-TL1A) Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
15-06-2026
yahoo.com
cAMPfield lands $180M to build gut disease drug
18-06-2026
biopharmadive.com
Spyre Therapeutics Shares Slide Following Large Insider Stock Sales (SYRE)
24-06-2026
advfn.com
Spyre Therapeutics Stock Outlook Hinges on 2026 Study Catalysts
29-06-2026
yahoo.com
Spyre Therapeutics Announces Grants of Inducement Awards
02-07-2026
yahoo.com
What is the current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The current price of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is $97.74.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) absolute price change since previous trading day?
The absolute price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is $-1.01.
SPYRE THERAPEUTICS INC (SYRE:NASDAQ) percentage price change since previous trading day?
The percentage price change of SPYRE THERAPEUTICS INC (SYRE:NASDAQ) since the previous trading day is -1.0228%.
What is the most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent average sentiment score for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ)?
The most recent sentiment for SPYRE THERAPEUTICS INC (SYRE:NASDAQ) is .
SEC-8K** Filing Available For SPYRE THERAPEUTICS INC (SYRE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.